Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Sales: 2024-2025

Historic Return on Sales for Kura Oncology (KURA) over the last 1 years, with Sep 2025 value amounting to -4.32%.

  • Kura Oncology's Return on Sales was N/A to -4.32% in Q3 2025 from the same period last year, while for Sep 2025 it was -4.32%, marking a year-over-year change of. This contributed to the annual value of -3.23% for FY2024, which is 10176.00% down from last year.
  • As of Q3 2025, Kura Oncology's Return on Sales stood at -4.32%, which was up 36.74% from -6.83% recorded in Q2 2025.
  • Kura Oncology's Return on Sales' 5-year high stood at 106.22% during Q4 2024, with a 5-year trough of -13.96% in Q1 2025.
  • Its 2-year average for Return on Sales is 20.28%, with a median of -5.57% in 2025.